1,2-dichloro-1,2,3,3,4,4-hexafluorocyclobutane has been researched along with gamma-aminobutyric acid in 4 studies
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liachenko, S; Somogyi, GT; Tang, P; Xu, Y | 1 |
Pearce, RA; Perouansky, M; Saad, AA; Zarnowska, ED | 1 |
Han, B; Kelz, MB; McCarren, HS; O'Neill, D | 1 |
Burkat, PM; Lor, C; Pearce, RA; Perouansky, M | 1 |
4 other study(ies) available for 1,2-dichloro-1,2,3,3,4,4-hexafluorocyclobutane and gamma-aminobutyric acid
Article | Year |
---|---|
Comparison of anaesthetic and non-anaesthetic effects on depolarization-evoked glutamate and GABA release from mouse cerebrocortical slices.
Topics: Anesthetics; Animals; Cerebral Cortex; Chlorofluorocarbons; Cyclobutanes; gamma-Aminobutyric Acid; Glutamic Acid; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL | 1998 |
The gamma-subunit governs the susceptibility of recombinant gamma-aminobutyric acid type A receptors to block by the nonimmobilizer 1,2-dichlorohexafluorocyclobutane (F6, 2N).
Topics: Anesthetics; Cell Line; Chloride Channels; Chlorofluorocarbons; Cyclobutanes; GABA Antagonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Humans; Membrane Potentials; Patch-Clamp Techniques; Recombinant Proteins | 2005 |
Distinctive recruitment of endogenous sleep-promoting neurons by volatile anesthetics and a nonimmobilizer.
Topics: Anesthetics; Animals; Chlorofluorocarbons; Cyclobutanes; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Mice; Mice, Inbred C57BL; Neurons; Preoptic Area; Proto-Oncogene Proteins c-fos; Recruitment, Neurophysiological; Sleep | 2014 |
Enhancement of α5-containing γ-aminobutyric acid type A receptors by the nonimmobilizer 1,2-dichlorohexafluorocyclobutane (F6) is abolished by the β3(N265M) mutation.
Topics: Anesthetics; Chlorofluorocarbons; Cyclobutanes; Dose-Response Relationship, Drug; GABA Modulators; gamma-Aminobutyric Acid; HEK293 Cells; Humans; Kinetics; Membrane Potentials; Mutation; Receptors, GABA-A | 2014 |